Vanguard Group
TXMD icon

Vanguard Group’s TherapeuticsMD TXMD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$440K Sell
379,001
-2,941
-0.8% -$3.41K ﹤0.01% 3947
2025
Q1
$353K Sell
381,942
-5,640
-1% -$5.22K ﹤0.01% 3964
2024
Q4
$333K Hold
387,582
﹤0.01% 4031
2024
Q3
$643K Hold
387,582
﹤0.01% 3908
2024
Q2
$624K Hold
387,582
﹤0.01% 3933
2024
Q1
$888K Hold
387,582
﹤0.01% 3855
2023
Q4
$872K Buy
387,582
+2,334
+0.6% +$5.25K ﹤0.01% 3876
2023
Q3
$1.16M Hold
385,248
﹤0.01% 3780
2023
Q2
$1.59M Hold
385,248
﹤0.01% 3739
2023
Q1
$1.44M Hold
385,248
﹤0.01% 3790
2022
Q4
$2.15M Buy
385,248
+124,837
+48% +$698K ﹤0.01% 3630
2022
Q3
$1.73M Sell
260,411
-105,383
-29% -$700K ﹤0.01% 3802
2022
Q2
$3.64M Sell
365,794
-17,082,430
-98% -$170M ﹤0.01% 3535
2022
Q1
$6.63M Sell
17,448,224
-2,681,156
-13% -$1.02M ﹤0.01% 3376
2021
Q4
$7.16M Buy
20,129,380
+1,218,593
+6% +$433K ﹤0.01% 3415
2021
Q3
$14M Buy
18,910,787
+299,574
+2% +$222K ﹤0.01% 3057
2021
Q2
$22.1M Buy
18,611,213
+519,864
+3% +$619K ﹤0.01% 2784
2021
Q1
$24.2M Buy
18,091,349
+4,925,705
+37% +$6.6M ﹤0.01% 2684
2020
Q4
$15.9M Buy
13,165,644
+392,936
+3% +$475K ﹤0.01% 2749
2020
Q3
$20.2M Buy
12,772,708
+203,369
+2% +$321K ﹤0.01% 2456
2020
Q2
$15.7M Sell
12,569,339
-4,420,623
-26% -$5.53M ﹤0.01% 2543
2020
Q1
$18M Buy
16,989,962
+394,737
+2% +$418K ﹤0.01% 2343
2019
Q4
$40.2M Buy
16,595,225
+1,975,568
+14% +$4.78M ﹤0.01% 2214
2019
Q3
$53.1M Buy
14,619,657
+56,968
+0.4% +$207K ﹤0.01% 2035
2019
Q2
$37.9M Buy
14,562,689
+788,467
+6% +$2.05M ﹤0.01% 2243
2019
Q1
$67.1M Buy
13,774,222
+478,726
+4% +$2.33M ﹤0.01% 1945
2018
Q4
$50.7M Buy
13,295,496
+401,469
+3% +$1.53M ﹤0.01% 2018
2018
Q3
$84.6M Buy
12,894,027
+1,153,716
+10% +$7.57M ﹤0.01% 1885
2018
Q2
$73.3M Buy
11,740,311
+346,070
+3% +$2.16M ﹤0.01% 1924
2018
Q1
$55.5M Sell
11,394,241
-9,585
-0.1% -$46.7K ﹤0.01% 2019
2017
Q4
$68.9M Buy
11,403,826
+493,701
+5% +$2.98M ﹤0.01% 1906
2017
Q3
$57.7M Buy
10,910,125
+679,044
+7% +$3.59M ﹤0.01% 1968
2017
Q2
$53.9M Buy
10,231,081
+429,211
+4% +$2.26M ﹤0.01% 1982
2017
Q1
$70.6M Buy
9,801,870
+515,992
+6% +$3.72M ﹤0.01% 1832
2016
Q4
$53.6M Buy
9,285,878
+214,461
+2% +$1.24M ﹤0.01% 1934
2016
Q3
$61.8M Buy
9,071,417
+321,259
+4% +$2.19M ﹤0.01% 1835
2016
Q2
$74.4M Buy
8,750,158
+2,994,369
+52% +$25.5M ﹤0.01% 1701
2016
Q1
$36.8M Buy
5,755,789
+676,748
+13% +$4.33M ﹤0.01% 2002
2015
Q4
$52.7M Buy
5,079,041
+294,113
+6% +$3.05M ﹤0.01% 1860
2015
Q3
$28M Buy
4,784,928
+800,150
+20% +$4.69M ﹤0.01% 2134
2015
Q2
$31.3M Buy
3,984,778
+176,632
+5% +$1.39M ﹤0.01% 2161
2015
Q1
$23M Buy
3,808,146
+455,793
+14% +$2.76M ﹤0.01% 2266
2014
Q4
$14.9M Buy
3,352,353
+259,601
+8% +$1.16M ﹤0.01% 2374
2014
Q3
$14.4M Buy
3,092,752
+278,786
+10% +$1.29M ﹤0.01% 2339
2014
Q2
$12.4M Buy
2,813,966
+154,745
+6% +$684K ﹤0.01% 2411
2014
Q1
$16.8M Buy
2,659,221
+645,757
+32% +$4.07M ﹤0.01% 2254
2013
Q4
$10.5M Buy
2,013,464
+885,716
+79% +$4.61M ﹤0.01% 2439
2013
Q3
$3.3M Buy
1,127,748
+79,360
+8% +$233K ﹤0.01% 2935
2013
Q2
$3.18M Buy
+1,048,388
New +$3.18M ﹤0.01% 2900